Namita Thapar To Gain ₹127.8 Cr From Emcure Pharma IPO

Emcure Pharmaceuticals IPO is set to start with a share sale on Wednesday, July 3.

The IPO is estimated to bring in about ₹127.87 crore for Namita Thapar, a well-known Shark Tank India investor and member of the Emcure Pharmaceuticals promoter group.

Thapar, who picked up shares of Emcure Pharmaceuticals at a weighted average price of ₹3.44 per share, would sell off a portion of his holdings, or around 12.68 lakh shares, through the offer for sale component

#namitathapar #emcurepharma #ipo #stockmarket #sharemarketnews #stocks #share

Want to make your money go further & work harder for you? Here are 20 Personal Finance Strategies from Mint. Check out our new coffee table book authored by Neil Borate & the Mint Money team. Download your digital copy .here! https://shorturl.at/dDUV1

Mint is an Indian financial daily newspaper published by HT Media. The Mint YT Channel brings you cutting edge analysis of the latest business news and financial news. With in-depth market coverage, explainers and expert opinions, we break down and simplify business news for you.

Click here to download the Mint App
https://livemint.onelink.me/MrDS/p0kx...